HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT03522545

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Depression in bipolarity

A short description of this study’s research objective has not yet been verified.

Placebo comparisonAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Houston, United StatesSee all locations and recruitment
Activities
Placebo comparator
Compensation
Payment and expense reimbursement have not been verified.

Registry last updated: · Record retrieved: . These dates do not confirm site availability.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 20, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
The University of Texas Health Science Center, Houston
Sponsor type
University
Study type
Biological
Intervention type
BIOLOGICAL
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03522545
Official title
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Want help reviewing this study?

Loading the security check...
Study ID: NCT03522545. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Houston

Checked Official study record (opens in a new tab)

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Texas Health Science Center, Houston, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
RecruitingNCT05703685

PET brain imaging study for depression

The registry lists this study as recruiting. Study locations are listed in the United States. Confirm recruitment at each site. It uses PET imaging to look at PDE4B in people with depression.